An introduction to economic issues in breast imaging

Area of Science:

• Health Economics
• Oncology
• Public Health Policy

Background:

• Rising healthcare expenditures and Medicare's role in elderly care have led to increased government regulation of medical reimbursement.
• Reimbursement rates from private insurers and Health Maintenance Organizations (HMOs) often mirror or fall below Medicare rates.
• Mammography reimbursement rates face particular restrictions, despite evidence of cost-effectiveness.

Purpose of the Study:

• To analyze the impact of screening mammography coverage on total healthcare costs.
• To evaluate the effect of early screening mammography (starting at age 40) on healthcare expenditures.
• To assess the relationship between mammography reimbursement policies and breast cancer mortality reduction.

Main Methods:

• Objective analysis of healthcare cost data related to screening mammography.
• Modeling the effect of including screening mammography coverage on overall healthcare spending.
• Comparative analysis of mammography's cost-effectiveness against other accepted medical interventions.

Main Results:

• Inclusion of screening mammography coverage, even from age 40, has a marginal effect on total healthcare costs.
• Reluctance from some third-party payors to reimburse screening mammography is based on perceived, rather than actual, significant cost increases.
• Adequate reimbursement for screening mammography is linked to a substantial decrease in breast cancer-related mortality.

Conclusions:

• Screening mammography is a cost-effective intervention for breast cancer prevention.
• Current reimbursement restrictions for mammography may hinder access to a vital screening tool.
• Policy changes supporting adequate mammography reimbursement can lead to significant public health benefits by reducing breast cancer deaths.